Medical Blog About Treatment Abroad

Esophageal cancer is still among the deadliest cancers of the digestive system, with about one out of every 20 cancer-related deaths worldwide. In 2022, over 500,000 new cases were diagnosed globally, and it is particularly high in East Asia and some parts of Africa. In the US, the American...

Cancer of the bowel can seem overwhelming initially, but learning about your diagnosis is a great first step toward feeling more in control of your health. Also known as colon cancer, it is a malignant growth in the large intestine, including the colon and rectum. It makes up about 7.6% of all new malignancy diagnoses in the USA...

Anal carcinoma is a rare but increasingly common, malignant neoplasm: the incidence has increased by approximately 2.7% per year over the past decade. Squamous cell carcinoma (SCC) accounts for about 85% of all cases, and a significant part of the diagnoses is HPV-positive anal squamous cell carcinoma. Although this type...

Glioblastoma (GBM) is the most common primary malignant tumor of the brain and accounts for about 16% of all primary neoplasms of the brain and central nervous system. The average age-standardized incidence rate is estimated at 3.2 cases per 100,000 population. As one of the most aggressive forms of brain cancer, glioblastoma...

Liver cancer remains one of the most pressing global health challenges of the 21st century. It is the third leading cause of cancer-related deaths worldwide, with hepatocellular carcinoma (HCC) accounting for the vast majority of cases. According to the Global Cancer Observatory, over 900,000 new liver cancer cases were diagnosed in 2022 alone...

Non-small cell lung cancer affects 85% of lung cancer patients, with stage III-IV cases having less than 5% five-year survival rates. While traditional treatments help only 30% of selected patients, innovative dendritic cell immunotherapy shows 50-65% effectiveness rates in clinical studies. These "immune system generals" train your body to fight...

Central airway tumors can be considered part of the spectrum of diseases related to head and neck cancer due to the anatomical and clinical proximity to the airways. Primary tracheal tumors (a type of airway cancer) are rare, but in adults they are usually cancerous, accounting for about 0.2% of all malignant tumors.

Oropharyngeal cancer (OPC) is a type of tumor that grows in the tissue of the oropharynx and includes malignancies of the tonsils, base of the tongue, posterior pharyngeal wall, and roof of the mouth. It is a part of a wide group of head and neck cancers (HNC) and shares the same origin from epithelial squamous cell tissue lining.